IPGG : Institute of Personalized Genomics and Gene Therapy

Knowledge in molecular genetics has fundamentally advanced our understanding of human disease; yet this advancement has been underutilized in clinical services and treatments for people living in Thailand and other South East Asian (SEA) eountries. Alack of ethnic-specific genetic research and inaccessibility to related technologies underlines the problem.

The Institute of Personalized Genomics and Gene Therapy(IPGG) is being established to satisfy this domestic and regional need for specialized information, knowledge, and patient care. IPGG is focusing on 3 main arenas: conducting comprehensive and cutting-edge Thai/SEA genetic research: applying genetic information to support diagnosis treatment, and policy making; and, providing training in genetics and bioinformatics to build up a critical mass of local researchers and medical doctors for the development of the nation.

IPGG is composed of teams of medical doctors, scientists, geneticsts, bioinformaticans, statisticians, and population scientists who work in close collaboration to bring about the moveldiscoveries and advancements with both theoretical and practical implication.

Institute of Personalized Genomics and Gene Therapy (IPGG) operates on personalized genomics and gene therapy research, one-stop personalized genomics and gene therapy service, including clinical database. The institute can be applied to the national health policy which is leading the country moving towards the top of ASEAN.

More information click here

The study of stem cells has become one of the mostly widely researched areas in medical science for the repair and replacement of damaged tissue and as an alternative treatment for diseases. Increasing levels of success in advanced transplantation surgery and the use of immunosuppressive drugs to decrease the rejection of transplanted tissues has
resulted in a shortage of solid organs for  transplantation. To reduce this shortage, scientists have focused their attention on the development of artificially grown organs and ways to repair organs for replacement. The use of stem cells to correct serious diseases and sub-system failures originated at Cambridge University in 1981 with the growth of stem cells from a mouse embryo. An American scientist later advanced stem cell research by growing stem cells from human embryo in 1998.
These early discoveries and the accelerating advancement of discoveries in the field of stem cell research have resulted
in the emergence of a new science Regenerative Medicine. This new science aims to find new ways to repair organs through the transplantation of stem cells that will generate new tissue growth to repair damaged organs or tissue structures. Stem cell research has been proliferating around the world, especially basic research on cell cultures and the growt h of stem cells into specialized cells. In Thailand, however, stem cell research has been limited by a lack of researchers and scientists with an expertise in stem cells. The Faculty of Medicine Siriraj Hospital has the capability of becoming the leader in stem cell research with the support of its GMP-standard laboratory infrastructure, state-of-the-art tools and equipment, experienced and qualified scientists and researchers with an interest in stem cell therapy, and a large number of stem cell therapy candidates. One current drawback that is slowing Siriraj Hospital’s advancement in stem cell research is a notable lack of physicians, scientists, and researchers who have specialized experience in the study of stem cells. In addressing this limitation and upgrading stem cell research in Thailand to match that of international levels, the Faculty of Medicine Siriraj Hospital established the  Siriraj Center of Excellence for Stem Cell Research (SiSCR). All researchers with a specialization in stem cells were invited to join the center and work together on developing new knowledge and potential stem cell technologies for use in diagnosis, analysis, and treatment of degenerated tissues or organs. The Center of Excellence for Stem Cell Research has a vision to be the leader in stem cell research in Thailand and Southeast Asia. It aims to provide training
to develop young researchers with stem cell specialization and to be the regional research and related technologies
transfer center for cooperation in the Asia-Pacific. Educating the general public on the use and benefits of stem cell
advancements and potential is also a key mission of SiSCR. This knowledge transfer to the general public will accelerate general acceptance of this emerging and promising medical science revolution. more information….

The Division of Dengue Hemorrhagic Fever Research is a research group operated under the Medical Molecular Biology Unit (MMBU), Office for Research and Development, Faculty of Medicine, Siriraj Hospital (Mahidol University). This division was founded in 1994 to conduct research in genomics, and molecular biology in dengue hemorrhagic fever and dengue virus and other related diseases.

Over the past 20 years, the research group has published well-known studies which were accepted by the scientific community in both Thailand and internationally.  On November 1st, 2010 the Unit has been approved to be set up as the Division of Dengue Hemorrhagic Fever Research supporting the expansion of dengue virus and dengue hemorrhagic fever research in of multi-disciplinary research fields.

The Division of Dengue Hemorrhagic Fever Research has been running a collaborative research network with the Medical Biotechnology Research Unit under a Memorandum of Understanding (MOU) between the Faculty of Medicine Siriraj Hospital and the National Center for Genetic Engineering and Biotechnology (BIOTEC) since 1994. Afterwards, the research network has expanded to include a collaboration with the Department of Microbiology, Faculty of Medicine, Chiang Mai University and the supported research funds cover equipment, research budgets and staff to achieve the unit’s mission. This collaboration has led to a strong research network and high quality research along with the expansion of basic research to translational research.

More information click here.